Skip to main content
Vericel Corporation (VCEL)
NASDAQ: VCEL · Real-Time Price · USD
57.54
+0.28 (0.49%)
Nov 21, 2024, 12:29 PM EST - Market open

Vericel Revenue

Vericel had revenue of $57.91M in the quarter ending September 30, 2024, with 27.04% growth. This brings the company's revenue in the last twelve months to $226.84M, up 22.48% year-over-year. In the year 2023, Vericel had annual revenue of $197.52M with 20.17% growth.

Revenue (ttm)
$226.84M
Revenue Growth
+22.48%
P/S Ratio
12.22
Revenue / Employee
$722,433
Employees
314
Market Cap
2.84B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023197.52M33.15M20.17%
Dec 31, 2022164.37M8.18M5.24%
Dec 31, 2021156.18M32.01M25.77%
Dec 31, 2020124.18M6.33M5.37%
Dec 31, 2019117.85M26.99M29.71%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Surgery Partners 2.99B
Concentra Group Holdings Parent 1.88B
LivaNova 1.24B
LifeStance Health Group 1.21B
Warby Parker 742.53M
Inari Medical 574.50M
Amicus Therapeutics 493.67M
SpringWorks Therapeutics 135.49M
Revenue Rankings

VCEL News

More News